company background image
A118000 logo

METACARE KOSE:A118000 Stock Report

Last Price

₩316.00

Market Cap

₩52.7b

7D

-1.6%

1Y

-20.8%

Updated

28 Nov, 2024

Data

Company Financials

A118000 Stock Overview

Distributes pharmaceuticals and medical devices in South Korea. More details

A118000 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

METACARE CO., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for METACARE
Historical stock prices
Current Share Price₩316.00
52 Week High₩684.00
52 Week Low₩305.00
Beta1.14
11 Month Change-6.78%
3 Month Change-21.98%
1 Year Change-20.80%
33 Year Change-78.43%
5 Year Change-87.15%
Change since IPO-96.64%

Recent News & Updates

A Piece Of The Puzzle Missing From METACARE CO., Ltd.'s (KRX:118000) Share Price

Nov 14
A Piece Of The Puzzle Missing From METACARE CO., Ltd.'s (KRX:118000) Share Price

SMEDI Co., Ltd. (KRX:118000) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jul 05
SMEDI Co., Ltd. (KRX:118000) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Recent updates

A Piece Of The Puzzle Missing From METACARE CO., Ltd.'s (KRX:118000) Share Price

Nov 14
A Piece Of The Puzzle Missing From METACARE CO., Ltd.'s (KRX:118000) Share Price

SMEDI Co., Ltd. (KRX:118000) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jul 05
SMEDI Co., Ltd. (KRX:118000) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Subdued Growth No Barrier To SMEDI Co., Ltd. (KRX:118000) With Shares Advancing 27%

Mar 07
Subdued Growth No Barrier To SMEDI Co., Ltd. (KRX:118000) With Shares Advancing 27%

There Are Some Holes In Wooridul Huebrain's (KRX:118000) Solid Earnings Release

Mar 22
There Are Some Holes In Wooridul Huebrain's (KRX:118000) Solid Earnings Release

What Type Of Returns Would Wooridul Huebrain's(KRX:118000) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Jan 31
What Type Of Returns Would Wooridul Huebrain's(KRX:118000) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Is Wooridul Huebrain (KRX:118000) Using Debt Sensibly?

Dec 25
Is Wooridul Huebrain (KRX:118000) Using Debt Sensibly?

Shareholder Returns

A118000KR HealthcareKR Market
7D-1.6%1.9%0.9%
1Y-20.8%-4.4%-3.4%

Return vs Industry: A118000 underperformed the KR Healthcare industry which returned -4.4% over the past year.

Return vs Market: A118000 underperformed the KR Market which returned -3.4% over the past year.

Price Volatility

Is A118000's price volatile compared to industry and market?
A118000 volatility
A118000 Average Weekly Movement3.6%
Healthcare Industry Average Movement8.4%
Market Average Movement5.7%
10% most volatile stocks in KR Market11.6%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A118000 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A118000's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200921Soo-Kyung Kimwww.smedi.net

METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory.

METACARE CO., Ltd. Fundamentals Summary

How do METACARE's earnings and revenue compare to its market cap?
A118000 fundamental statistics
Market cap₩52.73b
Earnings (TTM)-₩5.33b
Revenue (TTM)₩57.57b

0.9x

P/S Ratio

-9.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A118000 income statement (TTM)
Revenue₩57.57b
Cost of Revenue₩49.90b
Gross Profit₩7.68b
Other Expenses₩13.00b
Earnings-₩5.33b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-32.34
Gross Margin13.33%
Net Profit Margin-9.25%
Debt/Equity Ratio6.0%

How did A118000 perform over the long term?

See historical performance and comparison